A Personalized CYP2C19 Phenotype-Guided Dosing Regimen of Voriconazole Using a Population Pharmacokinetic Analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Personalized CYP2C19 Phenotype-Guided Dosing Regimen of Voriconazole Using a Population Pharmacokinetic Analysis
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 8, Issue 2, Pages 227
Publisher
MDPI AG
Online
2019-02-12
DOI
10.3390/jcm8020227
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients
- (2018) Xiao-bin Lin et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults
- (2018) Naveen Mangal et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Influence of different proton pump inhibitors on the pharmacokinetics of voriconazole
- (2017) Fang Qi et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The influence of combination use of CYP450 inducers on the pharmacokinetics of voriconazole: a systematic review
- (2017) T.-y. Li et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Impact of CYP2C19 Genotype and Liver Function on Voriconazole Pharmacokinetics in Renal Transplant Recipients
- (2017) Zi-Wei Li et al. THERAPEUTIC DRUG MONITORING
- Different effects of lansoprazole and rabeprazole on the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients
- (2016) Takeo Yasu et al. ANNALS OF HEMATOLOGY
- Genotype-Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation
- (2016) Ashley Teusink et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Dose-Dependent Bioavailability and CYP3A Inhibition Contribute to Non-Linear Pharmacokinetics of Voriconazole
- (2016) Nicolas Hohmann et al. CLINICAL PHARMACOKINETICS
- Determination of a suitable voriconazole pharmacokinetic model for personalised dosing
- (2015) David A. J. McDougall et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles
- (2015) Hyewon Chung et al. Drug Design Development and Therapy
- Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing
- (2014) M. J. Dolton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- CYP2C19Polymorphisms and Therapeutic Drug Monitoring of Voriconazole: Are We Ready for Clinical Implementation of Pharmacogenomics?
- (2014) Aniwaa Owusu Obeng et al. PHARMACOTHERAPY
- Identification of factors influencing the pharmacokinetics of voriconazole and the optimization of dosage regimens based on Monte Carlo simulation in patients with invasive fungal infections
- (2013) T. Wang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Integrated Population Pharmacokinetic Analysis of Voriconazole in Children, Adolescents, and Adults
- (2012) Lena E. Friberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
- (2012) Wan Beom Park et al. CLINICAL INFECTIOUS DISEASES
- Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacy and Safety: Population Pharmacokinetics–Based Analysis of Adult Patients With Invasive Fungal Infections
- (2012) Andres Pascual et al. CLINICAL INFECTIOUS DISEASES
- Population Pharmacokinetics of Voriconazole in Adults
- (2011) William W. Hope ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Voriconazole After Single and Multiple Doses in Healthy Volunteers
- (2011) SeungHwan Lee et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
- (2009) Ina Scholz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies
- (2008) M. O. Karlsson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comprehensive In Vitro Analysis of Voriconazole Inhibition of Eight Cytochrome P450 (CYP) Enzymes: Major Effect on CYPs 2B6, 2C9, 2C19, and 3A
- (2008) S. Jeong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now